Drug Quality and Security Act

enactedUnited States· United States Congress· EN

Introduced

27 September 2013

Last action

27 November 2013 · President

Status

Became Public Law No: 113-54.

Summary

Drug Quality and Security Act - Compounding Quality Act - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) with respect to the regulation of compounding drugs. Exempts compounded drugs from new drug requirements, labeling requirements, and track and trace requirements if the drug is compounded by or under the direct supervision of a licensed pharmacist in a registered outsourcing facility and meets applicable requirements. Establishes annual registration requirement for any outsourcing facility. Requires a facility to report biannually to the Secretary of Health and Human Services on what drugs are compounded in the facility and to submit adverse event reports. Subjects such facilities to a risk-based inspection schedule. Requires the Secretary to: (1) publish a list of drugs presenting demonstrable difficulties for compounding that are reasonably likely to lead to an adverse effect on the safety or effectiveness of the drug, taking into account the risk and benefits to patients; and (2) convene an advisory committee on compounding before creating the list. Requires the Secretary to assess an annual establishment fee on each outsourcing facility and a reinspection fee, as necessary. Prohibits the resale of a compounded drug labeled “not for resale,” or the intentional falsification of a prescription for a compounded drug. Deems a drug to be misbranded if the advertising or promotion of a compounded drug is false or misleading in any particular. Requires the Secretary to receive submissions from state boards of pharmacy: (1) describing any disciplinary actions taken against compounding pharmacies or any recall of a compounded drug, and (2) expressing concerns that a compounding pharmacy may be violating the FFDCA. Revises compounding pharmacy requirements to remove prohibitions on advertising and promotion by compounding pharmacies and remove requirement that prescriptions filled by a compounding pharmacy be unsolicited. Requires the Comptroller General (GAO) to report on pharmacy compounding and the adequacy of state and federal efforts to assure the safety of compounded drugs. Drug Supply Chain Security Act - Establishes requirements to facilitate the tracing of prescription drug products through the pharmaceutical supply distribution chain. Requires the Secretary to establish standards for the exchange of transaction documentation, which shall include transaction information, transaction history, and transaction statements. Requires the Secretary to establish processes to: (1) provide waivers of requirements, including for undue economic hardship or emergency medical reasons; (2) provide exceptions to requirements relating to product identifiers if a product is packaged without sufficient space to bear the information; and (3) determine other products or transactions that should be exempt from the requirements of this Act. Establishes requirements for drug manufacturers, wholesalers, dispensers, and repackagers to ensure that all prior transaction information is provided at each transfer of ownership. Requires a manufacturer, wholesale distributor, dispenser, and repackager, in the event of a recall or for the purpose of investigating a suspect product or an illegitimate product, to provide within a reasonable time the applicable transaction documentation upon request by the Secretary or other appropriate federal or state official. Requires a manufacturer or repackager to affix or imprint a product identifier on each package and homogenous case intended to be introduced in a transaction into commerce except for products that are required to have a standardized numerical identifier. Requires a manufacturer, wholesale distributor, dispenser, or repackager to ensure that each of its trading partners is authorized. Requires a manufacturer, wholesale distributor, dispenser, and repackager to implement systems to: (1) investigate suspect products; and (2) handle illegitimate products, including through quarantine, disposal, and appropriate notice to the Secretary and, as necessary, trading partners. Requires manufacturers, wholesale distributors, and repackagers to verify returned products before further distribution. Implements additional requirements related to the tracing of products at the package level ten years after enactment of this Act. Requires the Secretary to establish projects and hold public meetings to enhance the safety and security of the pharmaceutical distribution supply chain. Requires the Secretary to establish standards for the licensing of wholesale distributors and third party logistics providers. Preempts state and local requirements related to tracing drugs through the distribution system, and licensure of wholesale distributors and third party logistics providers.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

27 September 2013
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
27 September 2013
Introduced
Introduced in House
Source: IntroReferral
27 September 2013
Introduced
Introduced in House
Source: IntroReferral
28 September 2013
Passed
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5946-5960)
Source: Floor
28 September 2013
Passed
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5946-5960)
Source: Floor
28 September 2013
Floor
DEBATE - The House proceeded with forty minutes of debate on H.R. 3204.
Source: Floor
28 September 2013
Floor
Considered under suspension of the rules. (consideration: CR H5946-4965)
Source: Floor
28 September 2013
Floor
Mr. Upton moved to suspend the rules and pass the bill.
Source: Floor
30 September 2013
Introduced
Received in the Senate.
Source: IntroReferral
4 November 2013
Calendars
Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Source: Calendars
5 November 2013
Calendars
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 236.
Source: Calendars
6 November 2013
Floor
Motion to proceed to consideration of measure made in Senate. (consideration: CR S7841-7845, S7846-7864)
Source: Floor
7 November 2013
Floor
Motion to proceed to consideration of measure made in Senate. (consideration: CR S7891-7894, S7909-7920, S7923-7924)
Source: Floor
12 November 2013
Floor
Motion to proceed to consideration of measure made in Senate. (consideration: CR S7949-7950)
Source: Floor
13 November 2013
Floor
Motion to proceed to measure considered in Senate. (consideration: CR S7973-7996)
Source: Floor
14 November 2013
Passed
Motion to proceed to consideration of measure agreed to in Senate by Voice Vote.
Source: Floor
18 November 2013
Floor
Considered by Senate. (consideration: CR S8071-8076)
Source: Floor
18 November 2013
Passed
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.
Source: Floor
21 November 2013
Floor
Presented to President.
Source: Floor
21 November 2013
President
Presented to President.
Source: President
27 November 2013
Became law
Became Public Law No: 113-54.
Source: President
27 November 2013
Became law
Signed by President.
Source: BecameLaw
27 November 2013
President
Signed by President.
Source: President

Votes

No vote records are attached yet.

Versions

Enrolled Bill · — · Download file
Public Law · 28 November 2013 · Download file
Placed on Calendar Senate · 5 November 2013 · Download file
Engrossed in House · 28 September 2013 · Download file
Introduced in House · 27 September 2013 · Download file

Documents

12 official files

Enrolled Bill (text)

View file Download file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Enrolled Bill (text)
Enrolled Bill · EN
View Download Open at official source
Enrolled Bill (PDF)
Enrolled Bill · EN
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Public Law (text)
Public Law · EN · 28 November 2013
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Public Law (PDF)
Public Law · EN · 28 November 2013
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Public Law
summary · EN · 27 November 2013
Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Placed on Calendar Senate (text)
Placed on Calendar Senate · EN · 5 November 2013
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Placed on Calendar Senate (PDF)
Placed on Calendar Senate · EN · 5 November 2013
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in House (text)
Engrossed in House · EN · 28 September 2013
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in House (PDF)
Engrossed in House · EN · 28 September 2013
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 27 September 2013
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (PDF)
Introduced in House · EN · 27 September 2013
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 27 September 2013
Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

related to → Safeguarding America's Pharmaceuticals Act of 2013
related to ← Drug Supply Chain Security Act
related to ← Pharmaceutical Quality, Security, and Accountability Act
amends ← SAMDT 2007
amends ← SAMDT 2008
amends ← SAMDT 2024
amends ← To change the enactment date.
amends ← Of a perfecting nature.
amends ← To change the enactment date.

Showing 9 of 11 related records.

Related across the Repo ecosystem

Direct relationships are identifier-backed. Topic context means shared TopicMembership — not a citation and not causation.

Direct relationships

Legal framework · Drug Quality and Security Act · H.R. 3204 (113th) · US

Identifier matchPROJECTS_FROM
Same us record 113-hr-3204 projected from PoliticalRepo US row.
Drug Quality and Security Act

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/113th-congress/house-bill/3204
Open data entity: https://api.congress.gov/v3/bill/113/hr/3204
us · 113-hr-3204 · source updated 7 April 2025